Related Experiment Video

Updated: Jun 5, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

[Vascular calcification in chronic kidney disease]

Mario Cozzolino1, Elena Missaglia, Alberto Ortiz

  • 1Dipartimento di Medicina, Chirurgia e Odontoiatria, Ospedale S. Paolo, Milano. mariocozzolino@hotmail.com

Recenti Progressi in Medicina
|January 5, 2011
PubMed

Insights

Calcium-free phosphate binders may reduce cardiovascular risk in chronic kidney disease (CKD) patients by lowering phosphate and FGF-23 levels, addressing key issues in CKD-Mineral Bone Disorder (CKD-MBD).

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Endocrinology

Background:

  • Chronic kidney disease (CKD) is linked to secondary hyperparathyroidism and hyperphosphatemia.
  • CKD-Mineral Bone Disorder (CKD-MBD) now includes vascular calcification, a major risk factor for cardiovascular morbidity and mortality in CKD patients.
  • Phosphate control and understanding novel markers like FGF-23 are critical challenges in nephrology.

Purpose of the Study:

  • To explore the role of calcium-free phosphate binders in managing CKD-MBD.
  • To investigate the potential of these binders in reducing vascular calcification and associated cardiovascular risks.
  • To assess the impact on serum phosphate and FGF-23 levels.

Main Methods:

  • Review of current KDIGO guidelines and recent scientific literature.
  • Analysis of the mechanisms linking phosphate, FGF-23, vascular calcification, and cardiovascular outcomes in CKD.
  • Evaluation of the therapeutic potential of calcium-free phosphate binders.

Main Results:

  • Vascular calcification is a central component of CKD-MBD with significant cardiovascular implications.
  • FGF-23 is identified as a key mediator in the progression of vascular calcification and cardiovascular disease in CKD.
  • Calcium-free phosphate binders show promise in simultaneously managing serum phosphate and FGF-23 levels.

Conclusions:

  • Targeting phosphate and FGF-23 is crucial for mitigating cardiovascular risk in CKD patients.
  • Calcium-free phosphate binders represent a potential therapeutic strategy to improve outcomes in CKD-MBD.
  • Further research is warranted to confirm the clinical efficacy of these binders.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...